151 related articles for article (PubMed ID: 12468819)
1. Comparison of the faecal microflora of patients with ankylosing spondylitis and controls using molecular methods of analysis.
Stebbings S; Munro K; Simon MA; Tannock G; Highton J; Harmsen H; Welling G; Seksik P; Dore J; Grame G; Tilsala-Timisjarvi A
Rheumatology (Oxford); 2002 Dec; 41(12):1395-401. PubMed ID: 12468819
[TBL] [Abstract][Full Text] [Related]
2. Comparative immune responses to candidate arthritogenic bacteria do not confirm a dominant role for Klebsiella pneumonia in the pathogenesis of familial ankylosing spondylitis.
Stone MA; Payne U; Schentag C; Rahman P; Pacheco-Tena C; Inman RD
Rheumatology (Oxford); 2004 Feb; 43(2):148-55. PubMed ID: 12949256
[TBL] [Abstract][Full Text] [Related]
3. IgM, IgG, and IgA response to enterobacteria in patients with ankylosing spondylitis in southern India.
Madhavan R; Porkodi R; Rajendran CP; Chandrasekaran AN; Umadevi KR; Alamelu R
Ann N Y Acad Sci; 2002 Apr; 958():408-11. PubMed ID: 12021151
[TBL] [Abstract][Full Text] [Related]
4. Systemic and mucosal antibodies to Klebsiella in patients with ankylosing spondylitis and Crohn's disease.
O'Mahony S; Anderson N; Nuki G; Ferguson A
Ann Rheum Dis; 1992 Dec; 51(12):1296-300. PubMed ID: 1485810
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to Klebsiella pneumoniae, Escherichia coli, and Proteus mirabilis in ankylosing spondylitis: effect of sulfasalazine treatment.
Nissilä M; Lahesmaa R; Leirisalo-Repo M; Lehtinen K; Toivanen P; Granfors K
J Rheumatol; 1994 Nov; 21(11):2082-7. PubMed ID: 7869314
[TBL] [Abstract][Full Text] [Related]
6. Imbalance in intestinal microflora constitution could be involved in the pathogenesis of inflammatory bowel disease.
Takaishi H; Matsuki T; Nakazawa A; Takada T; Kado S; Asahara T; Kamada N; Sakuraba A; Yajima T; Higuchi H; Inoue N; Ogata H; Iwao Y; Nomoto K; Tanaka R; Hibi T
Int J Med Microbiol; 2008 Jul; 298(5-6):463-72. PubMed ID: 17897884
[TBL] [Abstract][Full Text] [Related]
7. The immune response to autologous bacteroides in ankylosing spondylitis is characterized by reduced interleukin 10 production.
Stebbings SM; Taylor C; Tannock GW; Baird MA; Highton J
J Rheumatol; 2009 Apr; 36(4):797-800. PubMed ID: 19228651
[TBL] [Abstract][Full Text] [Related]
8. [Antibodies to Klebsiella pneumoniae in ankylosing spondylitis].
Yuan GH; Shi GY; Ding YZ
Zhonghua Nei Ke Za Zhi; 1993 Jul; 32(7):467-9. PubMed ID: 8275826
[TBL] [Abstract][Full Text] [Related]
9. Association of gut inflammation with increased serum IgA class Klebsiella antibody concentrations in patients with axial ankylosing spondylitis (AS): implication for different aetiopathogenetic mechanisms for axial and peripheral AS?
Mäki-Ikola O; Leirisalo-Repo M; Turunen U; Granfors K
Ann Rheum Dis; 1997 Mar; 56(3):180-3. PubMed ID: 9135221
[TBL] [Abstract][Full Text] [Related]
10. Antibodies to Klebsiella pneumoniae lipopolysaccharide in patients with ankylosing spondylitis.
Ahmadi K; Wilson C; Tiwana H; Binder A; Ebringer A
Br J Rheumatol; 1998 Dec; 37(12):1330-3. PubMed ID: 9973159
[TBL] [Abstract][Full Text] [Related]
11. Antibodies to Klebsiella, Proteus, and HLA-B27 peptides in Japanese patients with ankylosing spondylitis and rheumatoid arthritis.
Tani Y; Tiwana H; Hukuda S; Nishioka J; Fielder M; Wilson C; Bansal S; Ebringer A
J Rheumatol; 1997 Jan; 24(1):109-14. PubMed ID: 9002020
[TBL] [Abstract][Full Text] [Related]
12. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of ankylosing spondylitis patients with/without iritis and enthesitis.
Mäki-Ikola O; Lehtinen K; Toivanen P; Granfors K
Br J Rheumatol; 1995 May; 34(5):418-20. PubMed ID: 7788169
[TBL] [Abstract][Full Text] [Related]
13. IgA class serum antibodies against three different Klebsiella serotypes in ankylosing spondylitis.
Mäki-Ikola O; Nissilä M; Lehtinen K; Granfors K
Br J Rheumatol; 1998 Dec; 37(12):1299-302. PubMed ID: 9973153
[TBL] [Abstract][Full Text] [Related]
14. Healthy individuals possess circulating antibodies against their indigenous faecal microflora as well as against allogenous faecal microflora: an immunomorphometrical study.
Apperloo-Renkema HZ; Jagt TG; Tonk RH; van der Waaij D
Epidemiol Infect; 1993 Oct; 111(2):273-85. PubMed ID: 8405154
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to Klebsiella pneumoniae, Escherichia coli and Proteus mirabilis in the sera of patients with axial and peripheral form of ankylosing spondylitis.
Mäki-Ikola O; Nissilä M; Lehtinen K; Leirisalo-Repo M; Toivanen P; Granfors K
Br J Rheumatol; 1995 May; 34(5):413-7. PubMed ID: 7788168
[TBL] [Abstract][Full Text] [Related]
16. A sequential study of the relationship between faecal Klebsiella aerogenes and the common clinical manifestations of ankylosing spondylitis.
Eastmond CJ; Calguner M; Shinebaum R; Cooke EM; Wright V
Ann Rheum Dis; 1982 Feb; 41(1):15-20. PubMed ID: 7039521
[TBL] [Abstract][Full Text] [Related]
17. [The peripheral joint syndrome in ankylosing spondylitis--one of the variants of reactive arthritis].
Guseĭnov NI; Nasonova EL; Baenskiĭ AV; Rubtsov OV
Ter Arkh; 1991; 63(5):63, 66-9. PubMed ID: 1887423
[TBL] [Abstract][Full Text] [Related]
18. Raised titres of anti-klebsiella IgA in ankylosing spondylitis, rheumatoid arthritis, and inflammatory bowel disease.
Cooper R; Fraser SM; Sturrock RD; Gemmell CG
Br Med J (Clin Res Ed); 1988 May; 296(6634):1432-4. PubMed ID: 3132277
[TBL] [Abstract][Full Text] [Related]
19. Absence of impaired lymphocyte transformation to Klebsiella spp. in ankylosing spondylitis.
Kinsella TD; Lanteigne C; Fritzler MJ; Lewkonia RM
Ann Rheum Dis; 1984 Aug; 43(4):590-3. PubMed ID: 6332581
[TBL] [Abstract][Full Text] [Related]
20. [Antibodies to Klebsiella pneumoniae in ankylosing spondylitis].
Mateicka F; Kozáková D; Cebecauer L; Ondrasík M; Bosmanský K
Cas Lek Cesk; 1989 Jan; 128(5):132-4. PubMed ID: 2676185
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
